Market Leadership Position 23mofang as China’s leading consumer genetics platform with Forbes recognition to leverage as a trust signal when approaching Chinese consumers, healthcare providers, and potential enterprise partners seeking consumer-focused genomic insights.

Growth Funding Capitalize on the Series B success and RMB 100 million funding to propose co-development, strategic investments, or joint ventures with VCs and corporate partners looking to scale consumer genomics in China.

Data Capability Emphasize the company’s mission to build a life-data database and offer data-driven genomic insights to consumer segments, enabling partnerships with DNA testing hardware manufacturers, health insurers, and lifestyle brands for personalized products.

Technology Stack Leverage the tech stack (Nuxt.js, Vue.js, analytics tools) to propose developer-focused collaborations, white-label solutions, or performance-based digital marketing services to boost platform adoption and user engagement.

Financial Tempo With current revenue in the low-to-mid millions and ongoing growth potential, explore tiered enterprise licensing, data access agreements, and collaboration for large-scale consumer genetics campaigns targeting Chinese consumers.